Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories

por Gkoliou, Glykeria, Agathangelidis, Andreas, Karakatsoulis, Georgos, Lalayanni, Chrysavgi, Papalexandri, Apostolia, Medina, Alejandro, Genuardi, Elisa, Chlichlia, Katerina, Hatjiharissi, Evdoxia, Papaioannou, Maria, Terpos, Evangelos, Jimenez, Cristina, Sakellari, Ioanna, Ferrero, Simone, Ladetto, Marco, Sanz, Ramon Garcia, Belessi, Chrysoula, Stamatopoulos, Kostas
Publicado 2023

Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia

por Drandi, Daniela, Genuardi, Elisa, Dogliotti, Irene, Ferrante, Martina, Jiménez, Cristina, Guerrini, Francesca, Schirico, Mariella Lo, Mantoan, Barbara, Muccio, Vittorio, Lia, Giuseppe, Zaccaria, Gian Maria, Omedè, Paola, Passera, Roberto, Orsucci, Lorella, Benevolo, Giulia, Cavallo, Federica, Galimberti, Sara, Sanz, Ramón García, Boccadoro, Mario, Ladetto, Marco, Ferrero, Simone
Publicado 2018

P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Ind...

por Driessen, Julia, De Wit, Fer, Herrera, Alex F., Zinzani, Pier Luigi, Lacasce, Ann S., Cole, Peter D., Moskowitz, Craig H., Sanz, Ramón. García, Fuchs, Michael, Müller, Horst, Borchmann, Peter, Santoro, Armando, Schöder, Heiko, Zijlstra, Josée. M., Hutten, Barbara A., Moskowitz, Alison J., Kersten, Marie José
Publicado 2022

T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri...

por Gallamini, Andrea, Picardi, Marco, Filonenko, Kateryna, Gotti, Manuel, Céspedes, Javier Núñez, Rossi, Andrea, Domingo-Domènech, Eva, Giza, Agnieszka, Sorasio, Roberto, Trentin, Livio, Oteiro, Mariana Bastos, Paszkiewicz-Kozik, Ewa, Sanz, Ramon García, Patti, Caterina, Chauvie, Stephane, Bergesio, Fabrizio, Guerra, Luca, Rambaldi, Alessandro, Balari, Ana Sureda, Zaucha, Jan Maciej
Publicado 2022

SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment

por Bastos Oreiro, Mariana, Martín, Reyes, Gomez, Pilar, López Muñoz, Nieves, Rodriguez, Antonia, Liébana, Marta, Navarro, Belén, Sánchez-González, Blanca, Marí, Pilar, Pérez de Oteiza, Jaime, Gutiérrez, Antonio, Bento, Leyre, Domingo Doménech, Eva, Vidal, María Jesús, Del Campo, Raquel, Pérez Ceballos, Elena, Infante, María, Roldán, Alicia, García Belmonte, Daniel, Santero, Miriam, Sureda, Anna, Sanz, Ramón García
Publicado 2021

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin...

por Sureda-Balari, Anna, Terol, M. José, Domingo-Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García
Publicado 2022